Side-by-side comparison of AI visibility scores, market position, and capabilities
AMS: HEIA second-largest global brewer at €30.3B FY2024 revenue with Heineken, Amstel, Dos Equis, and Tiger Beer across 190+ countries; Heineken 0.0 and Silver growth competing with AB InBev and Carlsberg for premium and no-alcohol beer.
Heineken N.V. is an Amsterdam, Netherlands-based global brewing company — listed on Euronext Amsterdam (AMS: HEIA) — operating the world's second-largest brewing company (by volume, behind AB InBev) with a portfolio of 300+ beer brands including Heineken (the flagship international lager), Amstel, Dos Equis, Tecate, Sol, Tiger Beer, Red Stripe, Birra Moretti, and 180+ regional and local brands distributed in 190+ countries through owned breweries, licensed brewing partners, and distribution partnerships. Heineken generated €30.3 billion in consolidated revenue in fiscal year 2024 (+2.1% organically) with 85,000+ employees across 70+ countries and 165 breweries — the product of a century of international acquisition and organic growth that transformed the 1873-founded Amsterdam brewer into the second-largest beer company globally.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.